NLRP8
geneOn this page
Also known as NOD16PAN4CLR19.2
Summary
NLRP8 (NLR family pyrin domain containing 8, HGNC:22940) is a protein-coding gene on chromosome 19q13.43, encoding NACHT, LRR and PYD domains-containing protein 8 (Q86W28). Involved in inflammation.
This gene encodes a member of the nucleotide-binding oligomerization domain/ leucine rich repeat/ pyrin domain containing (NLRP) subfamily, which belongs to the Nod-like receptor family of proteins. NLRP genes play roles in the mammalian innate immune system through inflammasome formation and activation of caspases. In addition, NLRP genes have been found to function during mammalian reproduction. Consistent with a function during human preimplantation development, this gene is expressed at high levels in oocytes with decreased levels in embryos. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 126205 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 198 total
- MANE Select transcript:
NM_001433706
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22940 |
| Approved symbol | NLRP8 |
| Name | NLR family pyrin domain containing 8 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NOD16, PAN4, CLR19.2 |
| Ensembl gene | ENSG00000179709 |
| Ensembl biotype | protein_coding |
| OMIM | 609659 |
| Entrez | 126205 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000291971, ENST00000590542, ENST00000850972
RefSeq mRNA: 2 — MANE Select: NM_001433706
NM_001317000, NM_001433706
CCDS: CCDS12937, CCDS82402
Canonical transcript exons
ENST00000850972 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001178447 | 55973652 | 55973822 |
| ENSE00001178459 | 55976133 | 55976303 |
| ENSE00001243768 | 55979394 | 55979564 |
| ENSE00001243785 | 55970544 | 55970696 |
| ENSE00001243793 | 55966213 | 55966380 |
| ENSE00001243800 | 55954501 | 55956100 |
| ENSE00001243805 | 55952538 | 55952612 |
| ENSE00001243826 | 55947832 | 55948269 |
| ENSE00001328716 | 55962067 | 55962237 |
| ENSE00004283098 | 55981059 | 55981158 |
Expression profiles
Bgee: expression breadth tissue_specific, 3 present calls, max score 90.47.
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 90.47 | gold quality |
| oocyte | CL:0000023 | 75.61 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.99 | gold quality |
| amniotic fluid | UBERON:0000173 | 60.24 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 58.66 | gold quality |
| ventral tegmental area | UBERON:0002691 | 56.11 | gold quality |
| mammary duct | UBERON:0001765 | 55.60 | gold quality |
| buccal mucosa cell | CL:0002336 | 55.57 | silver quality |
| jejunum | UBERON:0002115 | 55.43 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 54.20 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 53.96 | gold quality |
| jejunal mucosa | UBERON:0000399 | 53.44 | gold quality |
| gingival epithelium | UBERON:0001949 | 53.20 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 52.85 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 52.39 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 52.24 | gold quality |
| saphenous vein | UBERON:0007318 | 52.24 | gold quality |
| pericardium | UBERON:0002407 | 52.17 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 52.14 | gold quality |
| tongue | UBERON:0001723 | 52.13 | gold quality |
| medulla oblongata | UBERON:0001896 | 52.13 | gold quality |
| penis | UBERON:0000989 | 52.06 | gold quality |
| nipple | UBERON:0002030 | 52.00 | gold quality |
| synovial joint | UBERON:0002217 | 52.00 | gold quality |
| thymus | UBERON:0002370 | 52.00 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 51.87 | gold quality |
| trachea | UBERON:0003126 | 51.85 | gold quality |
| pylorus | UBERON:0001166 | 51.82 | gold quality |
| renal medulla | UBERON:0000362 | 51.80 | gold quality |
| body of tongue | UBERON:0011876 | 51.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.27 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
30 targeting NLRP8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-7845-5P | 99.88 | 64.88 | 771 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-5700 | 99.64 | 69.88 | 2280 |
| HSA-MIR-5689 | 99.50 | 71.26 | 1154 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-7854-3P | 99.08 | 66.26 | 1117 |
| HSA-MIR-6831-5P | 98.26 | 67.20 | 990 |
| HSA-MIR-5691 | 98.23 | 67.02 | 1335 |
| HSA-MIR-6805-3P | 98.23 | 67.02 | 1334 |
| HSA-MIR-4421 | 97.99 | 64.89 | 701 |
| HSA-MIR-5699-3P | 97.81 | 65.00 | 861 |
| HSA-MIR-3927-3P | 97.68 | 66.76 | 892 |
| HSA-MIR-6791-3P | 97.45 | 64.31 | 1123 |
| HSA-MIR-6829-3P | 97.45 | 64.31 | 1137 |
| HSA-MIR-526B-5P | 97.41 | 67.99 | 1074 |
Cross-species orthologs
0 orthologs
Paralogs (20): NLRP2 (ENSG00000022556), NLRP1 (ENSG00000091592), NOD1 (ENSG00000106100), NLRC5 (ENSG00000140853), NLRP12 (ENSG00000142405), NLRP14 (ENSG00000158077), NLRP4 (ENSG00000160505), NLRX1 (ENSG00000160703), NLRP3 (ENSG00000162711), NOD2 (ENSG00000167207), NLRP7 (ENSG00000167634), NLRC3 (ENSG00000167984), NLRP5 (ENSG00000171487), NLRP13 (ENSG00000173572), NLRP6 (ENSG00000174885), CIITA (ENSG00000179583), NLRP11 (ENSG00000179873), NLRP10 (ENSG00000182261), NLRP9 (ENSG00000185792), PYDC2 (ENSG00000253548)
Protein
Protein identifiers
NACHT, LRR and PYD domains-containing protein 8 — Q86W28 (reviewed: Q86W28)
Alternative names: Nucleotide-binding oligomerization domain protein 16, PYRIN and NACHT-containing protein 4
All UniProt accessions (1): Q86W28
UniProt curated annotations — full annotation on UniProt →
Function. Involved in inflammation.
Subcellular location. Cytoplasm.
Similarity. Belongs to the NLRP family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86W28-1 | 1 | yes |
| Q86W28-2 | 2 |
RefSeq proteins (2): NP_001303929, NP_001420635* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR004020 | DAPIN | Domain |
| IPR007111 | NACHT_NTPase | Domain |
| IPR011029 | DEATH-like_dom_sf | Homologous_superfamily |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR041075 | NOD1/2_WH | Domain |
| IPR041267 | NLRP_HD2 | Domain |
| IPR050637 | NLRP_innate_immun_reg | Family |
Pfam: PF02758, PF05729, PF13516, PF17776, PF17779
UniProt features (25 total): sequence variant 12, repeat 5, domain 2, region of interest 2, chain 1, compositionally biased region 1, binding site 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86W28-F1 | 80.26 | 0.40 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 210–217
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 28 (showing top):
GOBP_INFLAMMATORY_RESPONSE, HATADA_METHYLATED_IN_LUNG_CANCER_DN, GOBP_REGULATION_OF_RESPONSE_TO_STRESS, GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE, GOBP_REGULATION_OF_DEFENSE_RESPONSE, GOMF_ADENYL_NUCLEOTIDE_BINDING, LU_EZH2_TARGETS_DN, SRC_UP.V1_DN, ZNF146_TARGET_GENES, MIR8485, MIR4659A_3P_MIR4659B_3P, MIR5700, MIR7854_3P, JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP
GO Biological Process (1): regulation of inflammatory response (GO:0050727)
GO Molecular Function (3): ATP binding (GO:0005524), nucleotide binding (GO:0000166), protein binding (GO:0005515)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| inflammatory response | 1 |
| regulation of defense response | 1 |
| regulation of response to external stimulus | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
338 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NLRP8 | MEFV | O15553 | 744 |
| NLRP8 | CASP1 | P29466 | 585 |
| NLRP8 | OR10P1 | Q8NGE3 | 460 |
| NLRP8 | NLRC4 | Q9NPP4 | 396 |
| NLRP8 | NAIP | Q13075 | 384 |
| NLRP8 | IFNGR2 | P38484 | 371 |
| NLRP8 | IFNGR1 | P15260 | 360 |
| NLRP8 | ZNF804B | A4D1E1 | 323 |
| NLRP8 | CARD19 | Q96LW7 | 320 |
| NLRP8 | ZSCAN5B | A6NJL1 | 308 |
| NLRP8 | TRIM5 | Q9C035 | 306 |
| NLRP8 | NLRP1 | Q9C000 | 293 |
| NLRP8 | POTEC | B2RU33 | 290 |
| NLRP8 | ZSCAN5A | Q9BUG6 | 290 |
| NLRP8 | CARD8 | Q9Y2G2 | 289 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NLRP8 | DNAJB5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): DNAJB5 (Affinity Capture-MS), DNAJB4 (Affinity Capture-MS), NLRP8 (Affinity Capture-MS)
ESM2 similar proteins: A0A0G2JMD5, A1Z198, A3QJZ6, A3QJZ7, A6NGN4, D9I2F9, D9I2G1, D9I2G3, D9I2G4, D9I2H0, E9Q5G7, H0Y7S4, O60809, O60810, O60811, O60813, O95521, O95522, P0DUQ1, P0DUQ2, P78395, Q0GKD5, Q288C4, Q2LKU9, Q2LKV5, Q2LKW6, Q3TKR3, Q3UWY1, Q5SWL7, Q5SWL8, Q5TYX0, Q5VT98, Q5VTA0, Q5VWM3, Q5VWM4, Q5VWM6, Q5VXH4, Q5VXH5, Q66X05, Q66X19
Diamond homologs: A0A386CAB9, A1Z198, A6QLE5, B0FPE9, D4A523, D9I2F9, D9I2G1, D9I2G3, D9I2G4, D9I2H0, E9Q5R7, O15553, P10775, P13489, P29315, P59044, P59045, P59046, Q0GKD5, Q288C4, Q2LKU9, Q2LKV2, Q2LKV5, Q2LKW6, Q3TKR3, Q63035, Q647I9, Q66X01, Q66X03, Q66X19, Q6B966, Q7RTR0, Q86W24, Q86W25, Q86W26, Q86W28, Q8BU40, Q8C6J9, Q8CCN1, Q8HZP9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
198 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 162 |
| Likely benign | 12 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2095 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:55956099:GA:G | donor_gain | 1.0000 |
| 19:55956101:G:GG | donor_gain | 1.0000 |
| 19:55962062:T:G | acceptor_gain | 1.0000 |
| 19:55976301:GGA:G | donor_gain | 1.0000 |
| 19:55976302:GA:G | donor_gain | 1.0000 |
| 19:55976302:GAG:G | donor_gain | 1.0000 |
| 19:55976304:G:GG | donor_gain | 1.0000 |
| 19:55979384:T:A | acceptor_gain | 1.0000 |
| 19:55979565:G:GG | donor_gain | 1.0000 |
| 19:55981135:A:G | donor_gain | 1.0000 |
| 19:55981144:G:GT | donor_gain | 1.0000 |
| 19:55948234:A:AG | donor_gain | 0.9900 |
| 19:55948268:TGGT:T | donor_loss | 0.9900 |
| 19:55948269:GGT:G | donor_loss | 0.9900 |
| 19:55948270:G:GC | donor_loss | 0.9900 |
| 19:55952537:GCC:G | acceptor_gain | 0.9900 |
| 19:55954494:A:G | acceptor_gain | 0.9900 |
| 19:55954496:TCTA:T | acceptor_loss | 0.9900 |
| 19:55954497:CTAG:C | acceptor_loss | 0.9900 |
| 19:55954498:TA:T | acceptor_loss | 0.9900 |
| 19:55954499:AGGTA:A | acceptor_loss | 0.9900 |
| 19:55956094:GCTC:G | donor_gain | 0.9900 |
| 19:55962061:A:AG | acceptor_gain | 0.9900 |
| 19:55962065:A:AG | acceptor_gain | 0.9900 |
| 19:55962066:G:GG | acceptor_gain | 0.9900 |
| 19:55962066:GAGC:G | acceptor_gain | 0.9900 |
| 19:55962238:G:GG | donor_gain | 0.9900 |
| 19:55966062:A:AG | acceptor_gain | 0.9900 |
| 19:55970697:G:GG | donor_gain | 0.9900 |
| 19:55976131:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000114054 (19:55947819 T>A,C), RS1000165016 (19:55957579 G>A), RS1000221030 (19:55988628 G>A,C), RS1000225217 (19:55960534 A>G), RS1000244011 (19:55955135 G>A), RS1000297570 (19:55964113 G>A), RS1000359931 (19:55965091 G>T), RS1000385244 (19:55984525 A>G), RS1000453341 (19:55945845 G>A), RS1000646996 (19:55985079 G>A), RS1000790236 (19:55968036 A>G), RS1000816140 (19:55950688 G>A), RS1000831151 (19:55960217 G>A), RS1000837781 (19:55984728 T>C,G), RS1000921132 (19:55979011 C>T)
Disease associations
OMIM: gene MIM:609659 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001538_32 | Immune reponse to smallpox (secreted IFN-alpha) | 5.000000e-07 |
| GCST001762_317 | Obesity-related traits | 8.000000e-06 |
| GCST010206_11 | Anorectal malformation | 8.000000e-11 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004645 | response to vaccine |
| EFO:0004873 | cytokine measurement |
| EFO:0003940 | physical activity |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs306468 | NLRP8 | 0.00 | 0 |
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: catalytic receptor — NOD-like receptor family
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| benzo(e)pyrene | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): anorectal malformation